Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00328523
Status:
COMPLETED
Last Update Posted:
2022-02-18
First Post:
2006-05-19
Brief Title:
TWICE Ezetimibe Together With Any Statin Cholesterol Enhancement0653-060
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
Ezetimibe Together With Any Statin Cholesterol Enhancement
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In patients with primary hypercholesterolemia treated with a statin and with ldl-c above the recommended target goal esc 2003 recommendations ldl115 gl to compare the efficacy and the safety of ezetrol added to ongoing statin and non drug therapeutic intervention patient motivation on diet or physical activities or both
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006_024 | None | None | None |